AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease

RecruitingNAAges 18 Years - anyAllUniversity of Ulm
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate the influence of parasympathetic transmission from the brain to different metabolic organs. This transmission can be blocked with the muscarinic antagonist atropine. Participants will undergo an oral glucose tolerance test combined with a double tracer dilution technique either with atropine infusion or placebo. Healthy individuals and high-risk individuals will be compared to identify possible changes in signaling in high-risk groups. In addition, men and women will be included to take into account possible sex differences.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age: at least 18 * BMI: 20 - 24.9 kg/m2 (for the healthy groups) or more than 28 kg/m2 (for the overweight groups) * For women: Hormonal contraception with a single-phase preparation (e.g. Nuvaring) * Understanding and voluntarily signing an informed consent form prior to study-related examinations Exclusion Criteria: * Drug and/or alcohol abuse * smoking * Taking medication that affects blood sugar or addresses the central and/or autonomic nervous system (e.g. anti-epileptic drugs, beta blockers, dopamine agonists, antidepressants). Taking antihistamines. * Pre-existing cardiac conditions * Neurological pre-existing conditions * Known cardiac arrhythmia * Known allergies to ingredients, e.g. paracetamol and atropine * Known narrow-angle glaucoma * Known hyperthyroidism * Known diseases of the urinary tract or prostate * Pregnancy or breastfeeding * At screening: Hb \< 12 g/dl for women and Hb \< 14 g/dl for men * No consent to be informed about incidentally discovered pathological findings * Any (clinical) condition which, in the opinion of the physician, could jeopardize the safety of the * or would jeopardize the scientific success. * Liver dysfunction * Renal insufficiency
๐Ÿ’Š

What it tests

  • Oral glucose tolerance test with double-tracer dilution and atropine infusion
  • Oral glucose tolerance test with double-tracer dilution and saline infusion (placebo)
๐Ÿ“

Where

1 site
Ulm University Hospital
Ulm, Germany
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy